Tenax Therapeutics (TENX) Current Leases (2020 - 2021)
Tenax Therapeutics recorded quarterly Current Leases of $101461.0 in Q2 2021, up 230.03% quarter-over-quarter from $30743.0 in Q1 2021.
Tenax Therapeutics' Current Leases history runs 2 years deep, the most recent figure standing at $101461.0 for Q2 2021.
- In Q2 2021, Current Leases changed N/A year-over-year to $101461.0; the TTM figure through Jun 2021 stood at $101461.0 (changed N/A YoY), while the FY2020 annual figure was $60379.0, changed N/A from the prior year.
- Current Leases came in at $101461.0 for Q2 2021 at Tenax Therapeutics, up from $30743.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $101461.0 in Q2 2021 to a low of $30743.0 in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 101,461.00 |
| Mar 31, 2021 | 30,743.00 |
| Dec 31, 2020 | 60,379.00 |